Northern Trust Corp Forma Therapeutics Holdings, Inc. Transaction History

Northern Trust Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$7.12 - $20.24 $25,204 - $71,649	3,540 Added 1.02%	350,530 $6.99 Million
Q2 2022 Aug 12, 2022	BUY	$5.1 - $10.0 $184,487 - $361,740	36,174 Added 11.64%	346,990 $2.39 Million
Q1 2022 May 13, 2022	SELL	$8.34 - $14.69 $19,123 - $33,684	-2,293 Reduced 0.73%	310,816 $2.89 Million
Q4 2021 Feb 08, 2022	BUY	$13.6 - $24.89 $99,688 - $182,443	7,330 Added 2.4%	313,109 $4.45 Million
Q3 2021 Nov 15, 2021	BUY	$21.22 - $25.7 $376,103 - $455,506	17,724 Added 6.15%	305,779 $7.09 Million
Q2 2021 Aug 13, 2021	SELL	$22.86 - $30.95 $205,694 - $278,488	-8,998 Reduced 3.03%	288,055 $7.17 Million
Q1 2021 May 12, 2021	BUY	$24.58 - $42.82 $2.27 Million - $3.95 Million	92,156 Added 44.98%	297,053 $8.32 Million
Q4 2020 Feb 11, 2021	BUY	$34.9 - $51.08 $647,918 - $948,300	18,565 Added 9.96%	204,897 $7.15 Million
Q3 2020 Nov 16, 2020	BUY	$32.95 - $50.25 $6.14 Million - $9.36 Million	186,332 New	186,332 $9.29 Million

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.